These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 9781985

  • 1. Tumor reduction in vivo after adenoviral mediated gene transfer of the herpes simplex virus thymidine kinase gene and ganciclovir treatment in human head and neck squamous cell carcinoma.
    Goebel EA, Davidson BL, Graham SM, Kern JA.
    Otolaryngol Head Neck Surg; 1998 Oct; 119(4):331-6. PubMed ID: 9781985
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene.
    Smythe WR, Hwang HC, Elshami AA, Amin KM, Eck SL, Davidson BL, Wilson JM, Kaiser LR, Albelda SM.
    Ann Surg; 1995 Jul; 222(1):78-86. PubMed ID: 7618973
    [Abstract] [Full Text] [Related]

  • 5. Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model.
    Bilbao R, Gérolami R, Bralet MP, Qian C, Tran PL, Tennant B, Prieto J, Bréchot C.
    Cancer Gene Ther; 2000 May; 7(5):657-62. PubMed ID: 10830712
    [Abstract] [Full Text] [Related]

  • 6. Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk.
    Morris JC, Wildner O.
    Mol Ther; 2000 Jan; 1(1):56-62. PubMed ID: 10933912
    [Abstract] [Full Text] [Related]

  • 7. Use of protamine to augment adenovirus-mediated cancer gene therapy.
    Lanuti M, Kouri CE, Force S, Chang M, Amin K, Xu K, Blair I, Kaiser L, Albelda S.
    Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy.
    Lanuti M, Gao GP, Force SD, Chang MY, El Kouri C, Amin KM, Hughes JV, Wilson JM, Kaiser LR, Albelda SM.
    Hum Gene Ther; 1999 Feb 10; 10(3):463-75. PubMed ID: 10048398
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of pleural mesothelioma in an immunocompetent rat model utilizing adenoviral transfer of the herpes simplex virus thymidine kinase gene.
    Elshami AA, Kucharczuk JC, Zhang HB, Smythe WR, Hwang HC, Litzky LA, Kaiser LR, Albelda SM.
    Hum Gene Ther; 1996 Jan 20; 7(2):141-8. PubMed ID: 8788165
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of melanoma growth by adenoviral-mediated HSV thymidine kinase gene transfer in vivo.
    Bonnekoh B, Greenhalgh DA, Bundman DS, Eckhardt JN, Longley MA, Chen SH, Woo SL, Roop DR.
    J Invest Dermatol; 1995 Mar 20; 104(3):313-7. PubMed ID: 7860993
    [Abstract] [Full Text] [Related]

  • 12. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
    Ram Z, Culver KW, Walbridge S, Blaese RM, Oldfield EH.
    Cancer Res; 1993 Jan 01; 53(1):83-8. PubMed ID: 8380127
    [Abstract] [Full Text] [Related]

  • 13. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R, Amin K, Kiefer M, Jovanovic VP, Kapoor V, Force S, Chang M, Lanuti M, Black ME, Kaiser LR, Albelda SM.
    Cancer Gene Ther; 2003 May 01; 10(5):353-64. PubMed ID: 12719705
    [Abstract] [Full Text] [Related]

  • 14. Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase.
    Qian C, Bilbao R, Bruña O, Prieto J.
    Hepatology; 1995 Jul 01; 22(1):118-23. PubMed ID: 7601402
    [Abstract] [Full Text] [Related]

  • 15. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats.
    Ram Z, Walbridge S, Shawker T, Culver KW, Blaese RM, Oldfield EH.
    J Neurosurg; 1994 Aug 01; 81(2):256-60. PubMed ID: 8027810
    [Abstract] [Full Text] [Related]

  • 16. Safety of in vivo adenovirus-mediated thymidine kinase treatment of oral cancer.
    Sewell DA, Li D, Duan L, Westra WH, O'Malley BW.
    Arch Otolaryngol Head Neck Surg; 1997 Dec 01; 123(12):1298-302. PubMed ID: 9413357
    [Abstract] [Full Text] [Related]

  • 17. HSV-tk gene therapy in head and neck squamous cell carcinoma. Enhancement by the local and distant bystander effect.
    Wilson KM, Stambrook PJ, Bi WL, Pavelic ZP, Pavelic L, Gluckman JL.
    Arch Otolaryngol Head Neck Surg; 1996 Jul 01; 122(7):746-9. PubMed ID: 8663948
    [Abstract] [Full Text] [Related]

  • 18. Improvement of transduction efficiency of recombinant adenovirus vector conjugated with cationic liposome for human oral squamous cell carcinoma cell lines.
    Fukuhara H, Hayashi Y, Yamamoto N, Fukui T, Nishikawa M, Mitsudo K, Tohnai I, Ueda M, Mizuno M, Yoshida J.
    Oral Oncol; 2003 Sep 01; 39(6):601-9. PubMed ID: 12798404
    [Abstract] [Full Text] [Related]

  • 19. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
    Pulkkanen KJ, Parkkinen JJ, Laukkanen JM, Kettunen MI, Tyynela K, Kauppinen RA, Ala-Opas MY, Yla-Herttuala S.
    Cancer Gene Ther; 2001 Jul 01; 8(7):529-36. PubMed ID: 11498775
    [Abstract] [Full Text] [Related]

  • 20. Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy.
    Lambright ES, Amin K, Wiewrodt R, Force SD, Lanuti M, Propert KJ, Litzky L, Kaiser LR, Albelda SM.
    Gene Ther; 2001 Jun 01; 8(12):946-53. PubMed ID: 11426335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.